Standout Papers

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer 2022 2026 2023 2024300
  1. Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer (2022)
    Rom S. Leidner, David E. Sprott et al. New England Journal of Medicine

Citation Impact

1 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
The emerging role of lactate in tumor microenvironment and its clinical relevance
2024 Standout
2 intermediate papers

Works of Julie Cramer being referenced

A phase II trial of TGFβ type I receptor inhibitor, galunisertib, plus neoadjuvant chemoradiation in patients with locally advanced rectal cancer.
2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
2022 Standout

Author Peers

Author Oncology Neurology PRM Immunology Molecular Biology Last Decade Papers Cites
Julie Cramer 250 4 19 145 95 3 302
Syandan Chakraborty 66 7 13 58 1001 14 1.7k
R.T. Leonard 20 415
Ryan K. Beasley 17 409
S. Archer 11 9 78 11 301
Filip Fredén 6 8 498 13 18 29 718

All Works

Loading papers...

Rankless by CCL
2026